| Ashraf R Aziz, MD | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Ashraf R Aziz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386715365 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A53567 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Orange County - Anahe | Anaheim, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).
The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr Lluis Quintana-Murci (Human Evolutionary Genetics Unit, Institut Pasteur / CNRS) seek to establish the parameters that characterize the immune system of healthy individuals and its natural variability.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
Researchers from the McGill Group for Suicide Studies, based at the Douglas Mental Health University Institute and McGill University's Department of Psychiatry, have just published research in the American Journal of Psychiatry that suggests that the long-lasting effects of traumatic childhood experiences, like severe abuse, may be due to an impaired structure and functioning of cells in the anterior cingulate cortex.
› Verified 7 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).
The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr Lluis Quintana-Murci (Human Evolutionary Genetics Unit, Institut Pasteur / CNRS) seek to establish the parameters that characterize the immune system of healthy individuals and its natural variability.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
Researchers from the McGill Group for Suicide Studies, based at the Douglas Mental Health University Institute and McGill University's Department of Psychiatry, have just published research in the American Journal of Psychiatry that suggests that the long-lasting effects of traumatic childhood experiences, like severe abuse, may be due to an impaired structure and functioning of cells in the anterior cingulate cortex.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashraf R Aziz, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Ashraf R Aziz, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).
The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Pasteur / Inserm) and Dr Lluis Quintana-Murci (Human Evolutionary Genetics Unit, Institut Pasteur / CNRS) seek to establish the parameters that characterize the immune system of healthy individuals and its natural variability.
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
Researchers from the McGill Group for Suicide Studies, based at the Douglas Mental Health University Institute and McGill University's Department of Psychiatry, have just published research in the American Journal of Psychiatry that suggests that the long-lasting effects of traumatic childhood experiences, like severe abuse, may be due to an impaired structure and functioning of cells in the anterior cingulate cortex.
› Verified 7 days ago
Richard Eugene Hughes, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1300 N. Kraemer Blvd., Anaheim, CA 92806 Phone: 714-630-6363 Fax: 714-630-1921 | |
Michael Salvaggio, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente-orange County, 411 N. Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4594 | |
Abraham Harn, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave Ste 404, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Aleem A Syed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 702, Anaheim, CA 92801 Phone: 714-533-0300 Fax: 714-533-0700 | |
Dr. Jagminder Singh Bhalla, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1781 W Romneya Dr, Ste C, Anaheim, CA 92801 Phone: 714-956-3160 Fax: 714-956-1188 | |
Dr. Ashley E. Mires, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, #207, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Hyon Chong Seo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |